As of November 6, 2026, Capricor Therapeutics, Inc. is a publicly traded company (Nasdaq: CAPR); its largest reported holder is Tang Capital Management, LLC, with 7.1% on Schedule 13G/A of August 14, 2026, then Suvretta Capital Management, LLC (6.6%) (Schedule 13G/A, August 14, 2026).
Is this your company?
About to sign with, pay or invest in Capricor Therapeutics, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Capricor Therapeutics, Inc. a real, registered company?
- Capricor Therapeutics, Inc. files with the SEC under CIK 1133869 (its SEC filings).
- Its shares are listed under the ticker CAPR on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in San Diego, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Capricor Therapeutics, Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Millennium (filed 2026-09-14).
Who are Capricor Therapeutics, Inc.'s owners and officers?
Capricor Therapeutics, Inc.: incorporated in Delaware; business address in San Diego, California; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-10-14).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-10-14 | Millennium Management LLC | 2.9% |
| Schedule 13G, 2026-09-14 | Millennium Management LLC | 5.1% |
| Schedule 13G, 2026-08-19 | Millennium Management LLC | 4.9% |
| Schedule 13G/A, 2026-08-14 | Tang Capital Management, LLC | 7.1% |
| Schedule 13G, 2026-08-07 | State Street Corporation | 5.9% |
| Schedule 13G, 2026-08-03 | Ra Capital Management, L.P. | 5.2% |
| Schedule 13G, 2026-02-26 | Suvretta Capital Management, LLC | 6.6% |
| Schedule 13G/A, 2026-02-17 | Highbridge Capital Management, LLC | 2.3% |
| Schedule 13G, 2026-01-26 | Tang Capital Management, LLC | 6.6% |
| Schedule 13G/A, 2025-10-30 | The Vanguard Group | 4.82% |
| Schedule 13G, 2025-07-29 | The Vanguard Group | 5.04% |
Questions about who owns Capricor Therapeutics, Inc.
Who owns Capricor Therapeutics, Inc.?
On this page, 4 holders' latest ownership filings report 5% or more of Capricor Therapeutics, Inc.: Tang Capital Management, LLC (7.1%, Schedule 13G/A, filed 2026-08-14), Suvretta Capital Management, LLC (6.6%, Schedule 13G, filed 2026-02-26), State Street Corporation (5.9%, Schedule 13G, filed 2026-08-07) and Ra Capital Management, L.P. (5.2%, Schedule 13G, filed 2026-08-03).
Who are the largest shareholders of Capricor Therapeutics, Inc.?
By the share each holder's latest filing reports, the largest holders of Capricor Therapeutics, Inc. on this page are Tang Capital Management, LLC (7.1%), Suvretta Capital Management, LLC (6.6%) and State Street Corporation (5.9%).
When did Tang Capital Management, LLC buy into Capricor Therapeutics, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Tang Capital Management, LLC on this page is the Schedule 13G, filed 2026-01-26, reporting 6.6%; its latest, Schedule 13G/A filed 2026-08-14, reports 7.1%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 11 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Capricor Therapeutics, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Capricor Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Capricor Therapeutics, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
17 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Capricor Therapeutics, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief executive and a director: 211,104 shares (0.36% of shares outstanding) (Form 4, 2025-03-05).
- , a director: 180,054 shares (0.31% of shares outstanding), 133,776 held directly and 46,278 indirectly (Form 4, 2026-05-14).
- , a director: 57,606 shares (0.10% of shares outstanding) (Form 4, 2025-02-28).
- , the general counsel and executive vice president: 30,547 shares (0.05% of shares outstanding) (Form 4, 2026-06-29).
- , a director: 14,306 shares (0.02% of shares outstanding) (Form 4, 2025-12-23).
Shares outstanding: 58,138,989 as of 2026-08-13, from the company's latest SEC cover page.
How much has Capricor Therapeutics, Inc. raised?
No fundraising or offering filing from Capricor Therapeutics, Inc. is on file with us.
Keep reading
More on Capricor Therapeutics, Inc. and the records around it.
Capricor Therapeutics, Inc. elsewhere on the record
- 5%+ stake filings Oct 2026
Companies that share a holder
- SUVRETTA CAPITAL MANAGEMENT, LLC also filed stake reports on 22 other companies: Veradermics, Inc (Aug 2026), Abeona Therapeutics Inc. (Aug 2026), Fulcrum Therapeutics, Inc. (Aug 2026)
- TANG CAPITAL MANAGEMENT, LLC also filed stake reports on 33 other companies: EyePoint, Inc. (Oct 2026), Skye Bioscience, Inc. (Oct 2026), Nano Dimension Ltd. (Aug 2026)
- Highbridge Capital Management, LLC also filed stake reports on 83 other companies: Aeon Acquisition I Corp. (Aug 2026), Alpex Acquisition Corp (Aug 2026), Aperture AC (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/capricor-therapeutics